Small RNAs as important contributors in the cognitive symptoms associated with schizophrenia
Marcos Galán Ganga, Anna Guisado-Corcoll, Iván Ballasch, Marina Herrero-Lorenzo, Anna Sancho-Balsells, Belén Arranz, Albert Giralt, Eulàlia Martí · FENS Forum 2024
Schizophrenia is a neuropsychiatric syndrome that affects around 1% of the world population. It is characterized by psychotic or positive symptoms, negative symptoms and cognitive deficits. Currently, antipsychotic treatments can help to manage psychotic symptoms in acute episodes of schizophrenia. However, there is an unmet medical need for the treatment of those cognitive symptoms that appear since the premorbid phase and affect almost 98% of patients. Despite the identification of some molecular pathways that are impaired in schizophrenia, little is known about the possible contribution tha
ePoster · Neuroscience